Abstract

Glaucoma is the leading cause of irreversible vision loss. Ocular hypertension is a major risk factor for glaucoma and recent work has demonstrated critical early neuroinflammatory insults occur in the optic nerve head following ocular hypertension. Microglia and infiltrating monocytes are likely candidates to drive these neuroinflammatory insults. However, the exact molecular identity / transcriptomic profile of microglia following ocular hypertensive insults is unknown. To elucidate the molecular identity of microglia after long-term exposure to ocular hypertension, we used a mouse model of glaucoma (DBA/2 J). We performed RNA-sequencing of microglia mRNA from the optic nerve head at a time point following ocular hypertensive insults, but preceding detectable neurodegeneration (with microglia identified as being CD45lo/CD11b+/CD11c−). Furthermore, RNA-sequencing was performed on optic nerve head microglia from mice treated with radiation therapy, a potent therapy preventing neuroinflammatory insults. Transcriptomic profiling of optic nerve head microglia mRNA identifies metabolic priming with marked changes in mitochondrial gene expression, and changes to phagocytosis, inflammatory, and sensome pathways. The data predict that many functions of microglia that help maintain tissue homeostasis are affected. Comparative analysis of these data with data from previously published whole optic nerve head tissue or monocyte-only samples from DBA/2 J mice demonstrate that many of the neuroinflammatory signatures in these data sets arise from infiltrating monocytes and not reactive microglia. Finally, our data demonstrate that prophylactic radiation therapy of DBA/2 J mice potently abolishes these microglia metabolic transcriptomic changes at the same time points. Together, our data provide a unique resource for the community to help drive further hypothesis generation and testing in glaucoma.

Highlights

  • Glaucoma is one of the most common neurodegenerations affecting an estimated 80 million people worldwide [1]

  • Transcriptomic profiling of optic nerve head microglia We performed RNA-sequencing on CD45lo/CD11b+/ CD11c− microglia samples from DBA/2 J (D2), control D2-Gpnmb+, and radiation treated DBA/2 J (D2-Radiation treated / irradiation therapy (RAD)) mice isolated from single optic nerve heads (ONHs) and enriched through FAC sorting

  • The current study focuses on CD11c− microglia, the most prominent microglia subtype in our previous datasets

Read more

Summary

Introduction

Glaucoma is one of the most common neurodegenerations affecting an estimated 80 million people worldwide [1]. It is a complex and multifactorial disease characterised by the progressive dysfunction and loss of retinal ganglion cells and their axons (that make up the optic nerve). A common theme between animal models and human glaucoma is the activation or reactivity of glial cells in the retina, optic nerve, and optic nerve head [2,3,4,5,6,7]. Activated microglia are known to affect the progression of neurodegenerative diseases due to their influence over homeostatic and immune responses. Given the primary role of microglia in regulating neuroinflammation (such as in Alzheimer’s disease [8,9,10,11]), identifying any dysregulation of microglia is of paramount importance for the development of neuroprotective treatments [12]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call